From day one, Alder has worked to make a significant contribution to the field of antibody therapeutics using two proprietary platform technologies that accelerate antibody discovery and development. These technologies provide the foundation for addressing a range of unmet medical needs, and have allowed us to accelerate our first product into the clinic for the treatment of cancer and rheumatoid arthritis.
